Fresenius Kabi Set To Expand In Emerging Markets, CEO Says
This article was originally published in PharmAsia News
Executive Summary
Fresenius Kabi, a unit of the Fresenius Germany-based holding company, is being promoted as a company with the potential to widen its offerings to grow in emerging markets with its generic infusion drugs.